educational

Hernia Mesh Complications — What Can Go Wrong

Preparing your case review…
Written By
People's Justice Legal Research Team

The Spectrum of Hernia Mesh Complications

Hernia mesh complications range from relatively minor wound-healing issues to life-threatening emergencies. The nature of the complication — and whether it is attributable to a mesh design defect versus an unavoidable surgical risk — is the central question in every legal claim. Manufacturers argue that some complication rate is inherent in any surgical implant. Plaintiffs respond that defendants knew their specific products produced complication rates significantly above the industry baseline and concealed this from surgeons and patients who might have chosen a different product or approach.

Mesh Migration

Mesh migration occurs when the implant shifts from its original surgical position. Polypropylene undergoes contracture over time — shrinking and stiffening as the inflammatory response matures — which can pull the mesh away from its fixation points. A migrated mesh can fold, bunch, or displace into the peritoneal cavity where it contacts bowel and blood vessels. Patients may feel a new lump or hardness at the surgical site, experience new pain patterns, or develop bowel symptoms. Diagnosis requires CT scan or MRI imaging. Treatment typically requires surgical revision.

Adhesion Formation and Bowel Obstruction

Adhesions are fibrous scar tissue bands that form between the mesh and adjacent structures. When polypropylene contacts the bowel, it triggers a chronic inflammatory response that can produce dense adhesions binding the mesh to the intestine, bladder, or other organs. Mild adhesions cause chronic pain and intermittent GI symptoms. Severe adhesions can cause complete bowel obstruction — a surgical emergency with 25-30% mortality if not treated promptly. Bowel obstruction due to mesh adhesion is one of the most serious complications in hernia mesh litigation and typically produces the highest settlement and verdict values.

Surgical Site Infection and Mesh Biofilm

Mesh infection is particularly devastating because bacteria form biofilms within the mesh fiber matrix that are resistant to antibiotic penetration. Unlike soft tissue infections that respond to antibiotics, mesh biofilm infections typically require complete surgical removal of the device. Patients may endure months of antibiotic therapy, wound VAC placement, and multiple surgical debridements before surgeons determine that complete explantation is necessary. After explantation, patients face the risk of hernia recurrence because the mesh reinforcement has been removed.

Mesh Shrinkage and Contracture

All polypropylene mesh undergoes some degree of in vivo shrinkage as the body encapsulates it with scar tissue — a process called fibrotic contracture. In defective products, this shrinkage is excessive, reducing the effective coverage area of the mesh and causing it to pull against anchoring sutures or fixation tacks. Contracture-related pain is often described as a persistent pulling or burning sensation that worsens with physical activity. In inguinal repairs, contracture can compress the spermatic cord structures in male patients, causing testicular atrophy.

Nerve Damage and Chronic Pain (Inguinodynia)

The inguinal region contains three major sensory nerves — the ilioinguinal, iliohypogastric, and genitofemoral nerves — that are at risk during inguinal hernia mesh placement and fixation. Mesh fixation devices (tacks, staples, sutures) can directly puncture or compress these nerves. As the mesh shrinks and the surrounding scar tissue matures, nerves can become entrapped in the fibrotic matrix. The resulting inguinodynia — chronic groin pain — is often burning, shooting, or hypersensitive in character, and frequently proves refractory to standard pain management. Neurectomy (surgical nerve division) may provide relief but is not universally effective once nerve damage has occurred.

FAQ

Frequently Asked Questions

See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
Related Topics

Related Pages

Davol and C.R. Bard Hernia Mesh Products

Davol Inc. and its parent C.R. Bard (now Becton Dickinson) manufactured the largest portfolio of recalled and litigation-linked hernia mesh products in the United States. Products including 3DMax, Ventralex ST, and the recalled Composix Kugel are at the center of MDL 2846 — one of the largest active medical device MDLs in federal court.

davolcr-bardhernia-mesh
Learn more

Hernia Mesh Infection Claims

Hernia mesh infection is a devastating complication because bacteria colonize the mesh material in treatment-resistant biofilms, usually requiring complete surgical removal. Mesh design characteristics — including pore size, material composition, and surface coatings — directly affect infection susceptibility, creating strong product liability theories.

mesh-infectionbiofilmsepsis
Learn more

Hernia Mesh Settlements — What to Expect

Hernia mesh mass tort settlements are structured as tiered grids based on injury severity, number of revision surgeries, and individual case factors. Understanding how settlement grids work and what factors increase your tier placement helps you evaluate your claim and avoid accepting inadequate offers.

hernia-mesh-settlementsettlement-gridmass-tort
Learn more

Hernia Mesh Evidence — Building Your Claim

A strong hernia mesh claim rests on three evidentiary pillars: confirmed product identification (which specific mesh was implanted), documented complications in medical records, and expert opinions causally linking the mesh to the injuries. Gathering and preserving this evidence from the moment complications are identified is the single most important step a potential claimant can take.

hernia-mesh-evidenceproduct-identificationoperative-report
Learn more

Ethicon and Johnson and Johnson Hernia Mesh

Ethicon, a Johnson and Johnson subsidiary, manufactured the Physiomesh Flexible Composite — voluntarily withdrawn from global markets in May 2016 after independent registry data revealed reoperation rates two to three times higher than comparator meshes. Ethicon Physiomesh and related product claims are consolidated in MDL 2753 in the District of New Jersey and MCL 616 in New Jersey Superior Court.

ethiconjohnson-johnsonphysiomesh
Learn more

Hernia Mesh Revision Surgery — What It Involves

Hernia mesh revision surgery — including adhesiolysis, partial mesh removal, and complete explantation — is a significantly more complex and dangerous operation than the original hernia repair. The risks, costs, and recovery demands of revision surgery are core elements of damages in hernia mesh litigation.

revision-surgerymesh-explantationadhesiolysis
Learn more

Hernia Mesh Recall History — What the FDA Found

The FDA has issued safety communications, ordered 522 post-market surveillance studies, and presided over multiple hernia mesh recalls. The regulatory history establishes that manufacturers had notice of mesh complications well before many patients were implanted — a critical element of failure-to-warn and design defect claims.

hernia-mesh-recallfdacomposix-kugel
Learn more

Inguinal Hernia Mesh Claims

Inguinal hernia mesh repairs are the most common hernia surgery in the United States, accounting for approximately 800,000 procedures annually. The inguinal region's proximity to critical nerves and spermatic cord structures makes mesh complications in this location particularly likely to cause chronic, debilitating pain.

inguinal-herniateptapp
Learn more

Ventral Hernia Mesh Claims

Ventral hernias — including incisional hernias following prior abdominal surgeries — are typically repaired with large sheets of synthetic mesh placed intra-abdominally or in the retromuscular space. The large surface area of ventral mesh in contact with bowel creates significant risk of adhesion, migration, and bowel obstruction.

ventral-herniaincisional-herniaumbilical-hernia
Learn more

Hernia Mesh MDL 2846 — What You Need to Know

MDL 2846 in the Southern District of Ohio is the federal coordination for all Davol/C.R. Bard hernia mesh cases. With over 20,000 cases and ongoing bellwether trials, understanding how the MDL works is essential for any potential claimant navigating this litigation.

mdl-2846multidistrict-litigationsouthern-district-ohio
Learn more

Hernia Mesh Chronic Pain — Inguinodynia Claims

Chronic groin pain (inguinodynia) following hernia mesh repair affects an estimated 10 to 30 percent of patients in some surgical registry studies and is the most common basis for hernia mesh legal claims. Nerve entrapment by mesh fixation devices and mesh contracture are the primary mechanisms. Chronic pain claims are legally cognizable even without revision surgery.

inguinodyniachronic-painnerve-entrapment
Learn more
Parent Case

Hernia Mesh (Davol/C.R. Bard) Lawsuit

Hernia mesh litigation is one of the largest ongoing mass tort actions in the United States. Polypropylene mesh devices implanted during inguinal, ventral, and incisional hernia repairs have been associated with a pattern of serious defects — including mesh shrinkage, migration, erosion into adjacent organs, bacterial colonization, and nerve entrapment — that manufacturers knew about for years before disclosing to physicians or patients. The primary defendants include Davol Inc. and its parent C.R. Bard (now part of Becton Dickinson), Ethicon (a Johnson and Johnson subsidiary), Atrium Medical, and Covidien (now part of Medtronic). The federal multidistrict litigation MDL 2846 in the Southern District of Ohio has consolidated thousands of Davol/C.R. Bard claims for coordinated pre-trial proceedings. Separately, Ethicon mesh cases are coordinated in New Jersey Superior Court (MCL 616). Patients who underwent hernia repair surgery and subsequently experienced complications are urged to seek legal evaluation immediately — statutes of limitations are running and evidence must be preserved.

View full case overview